138 related articles for article (PubMed ID: 25917396)
1. Investigation of the GPR39 zinc receptor following inhibition of monoaminergic neurotransmission and potentialization of glutamatergic neurotransmission.
Młyniec K; Gaweł M; Librowski T; Reczyński W; Bystrowska B; Holst B
Brain Res Bull; 2015 Jun; 115():23-9. PubMed ID: 25917396
[TBL] [Abstract][Full Text] [Related]
2. The involvement of the GPR39-Zn(2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims.
Młyniec K; Doboszewska U; Szewczyk B; Sowa-Kućma M; Misztak P; Piekoszewski W; Trela F; Ostachowicz B; Nowak G
Neuropharmacology; 2014 Apr; 79():290-7. PubMed ID: 24333148
[TBL] [Abstract][Full Text] [Related]
3. GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB/BDNF down-regulation in the hippocampus.
Młyniec K; Budziszewska B; Holst B; Ostachowicz B; Nowak G
Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25609596
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of the GPR39 Zn2+-sensing receptor and CREB/BDNF/TrkB pathway after chronic but not acute antidepressant treatment in the frontal cortex of zinc-deficient mice.
Młyniec K; Nowak G
Pharmacol Rep; 2015 Dec; 67(6):1135-40. PubMed ID: 26481532
[TBL] [Abstract][Full Text] [Related]
5. Study of antidepressant drugs in GPR39 (zinc receptor⁻/⁻) knockout mice, showing no effect of conventional antidepressants, but effectiveness of NMDA antagonists.
Młyniec K; Gaweł M; Nowak G
Behav Brain Res; 2015; 287():135-8. PubMed ID: 25827929
[TBL] [Abstract][Full Text] [Related]
6. The role of the GPR39 receptor in zinc deficient-animal model of depression.
Młyniec K; Budziszewska B; Reczyński W; Sowa-Kućma M; Nowak G
Behav Brain Res; 2013 Feb; 238():30-5. PubMed ID: 23089648
[TBL] [Abstract][Full Text] [Related]
7. Chronic memantine disrupts spatial memory and up-regulates Htr1a gene expression in the hippocampus of GPR39 (zinc-sensing receptor) KO male mice.
Rychlik M; Starnowska-Sokol J; Mlyniec K
Brain Res; 2023 Dec; 1821():148577. PubMed ID: 37716463
[TBL] [Abstract][Full Text] [Related]
8. Lack of BDNF expression through promoter IV disturbs expression of monoamine genes in the frontal cortex and hippocampus.
Sakata K; Duke SM
Neuroscience; 2014 Feb; 260():265-75. PubMed ID: 24345476
[TBL] [Abstract][Full Text] [Related]
9. GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development?
Młyniec K; Singewald N; Holst B; Nowak G
J Affect Disord; 2015 Mar; 174():89-100. PubMed ID: 25490458
[TBL] [Abstract][Full Text] [Related]
10. Immune malfunction in the GPR39 zinc receptor of knockout mice: Its relationship to depressive disorder.
Młyniec K; Trojan E; Ślusarczyk J; Głombik K; Basta-Kaim A; Budziszewska B; Skrzeszewski J; Siwek A; Holst B; Nowak G
J Neuroimmunol; 2016 Feb; 291():11-7. PubMed ID: 26857489
[TBL] [Abstract][Full Text] [Related]
11. A possible significant role of zinc and GPR39 zinc sensing receptor in Alzheimer disease and epilepsy.
Khan MZ
Biomed Pharmacother; 2016 Apr; 79():263-72. PubMed ID: 27044837
[TBL] [Abstract][Full Text] [Related]
12. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
[TBL] [Abstract][Full Text] [Related]
13. The role of GPR39 zinc receptor in the modulation of glutamatergic and GABAergic transmission.
Starowicz G; Siodłak D; Nowak G; Mlyniec K
Pharmacol Rep; 2023 Jun; 75(3):609-622. PubMed ID: 36997827
[TBL] [Abstract][Full Text] [Related]
14. GPR39 up-regulation after selective antidepressants.
Młyniec K; Nowak G
Neurochem Int; 2013 Jun; 62(7):936-9. PubMed ID: 23474197
[TBL] [Abstract][Full Text] [Related]
15. Long-lasting antidepressant-like activity of the GPR39 zinc receptor agonist TC-G 1008.
Starowicz G; Jarosz M; Frąckiewicz E; Grzechnik N; Ostachowicz B; Nowak G; Mlyniec K
J Affect Disord; 2019 Feb; 245():325-334. PubMed ID: 30419533
[TBL] [Abstract][Full Text] [Related]
16. Potential antidepressant-like properties of the TC G-1008, a GPR39 (zinc receptor) agonist.
Młyniec K; Starowicz G; Gaweł M; Frąckiewicz E; Nowak G
J Affect Disord; 2016 Sep; 201():179-84. PubMed ID: 27235821
[TBL] [Abstract][Full Text] [Related]
17. Activation of dopaminergic neurotransmission in the medial prefrontal cortex by N-methyl-d-aspartate stimulation of the ventral hippocampus in rats.
Peleg-Raibstein D; Pezze MA; Ferger B; Zhang WN; Murphy CA; Feldon J; Bast T
Neuroscience; 2005; 132(1):219-32. PubMed ID: 15780480
[TBL] [Abstract][Full Text] [Related]
18. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
Howells FM; Russell VA
Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191
[TBL] [Abstract][Full Text] [Related]
19. Modulation by serotonin of glutamate-induced lethality in mice.
Kamei J; Igarashi H; Kasuya Y
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):167-84. PubMed ID: 1839809
[TBL] [Abstract][Full Text] [Related]
20. Specificity and efficacy of noradrenaline, serotonin depletion in discrete brain areas of Swiss mice by neurotoxins.
Dailly E; Chenu F; Petit-Demoulière B; Bourin M
J Neurosci Methods; 2006 Jan; 150(1):111-5. PubMed ID: 16098600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
